A review of emerging circulating biomarkers and clinical strategies for integrating liquid biopsy into early multi-cancer detection programs.
Key Takeaways
- Future directions will be presented to identify new methods of integration
- Detecting cancer early is a universally accepted factor in improving patient outcomes
- Although newly developed treatment regimens have greatly improved the prognosis of many patients